ClinicalTrials.govpublic full text
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts
major depressive disorder (mdd), ketamine, positron emission tomography (pet), kappa opioid receptor, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 826548
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.